FDA approves generic version of EpiPen

The Food and Drug Administration Thursday approved a new generic version of the  EpiPen, a move that could drive down the price and increase the availability of the emergency allergy medication auto-injector. The generic version will be made by Teva Pharmaceuticals USA (NYSE:TEVA) in 0.3 mg and 0.15 mg strengths, the New York Times reported.  EpiPen manufacturer Mylan has c ome under intense criticism for raising the price of the medication, which is used by people with severe allergies to prevent…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news